Eukaryotic translation initiation factor 4B pseudogene 7 (EIF4BP7)

EIF4BP7 stands for "Eukaryotic translation initiation factor 4B pseudogene 7." Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they do not encode active proteins. There is no evidence that EIF4BP7 is a receptor, enzyme, or druggable target. It does not participate in signal transduction, translation, or other canonical cellular pathways attributed to functional translation initiation factors (like EIF4E, EIF4G, or EIF4B). As such, EIF4BP7 is not considered a therapeutic target, and there is no evidence linking it directly to disease, drug interactions, biomarker status, or safety concerns.\n- If you intended to refer to a functional member of the eukaryotic translation initiation factor family (such as EIF4E or EIF4B), those are separate and well-established translation initiation factors[2][3]. EIF4BP7, as a pseudogene, is not equivalent to these.\n- The structure and function described in the search results for translation initiation factors such as EIF4E do not apply to EIF4BP7, as this pseudogene does not produce a functional translation factor protein.\nSummary of Issues with the Query:\n- EIF4BP7 is a pseudogene, not a functional molecule or receptor.\n- Not a therapeutic target and therefore not typically included in drug screening or disease association studies.\n- No aliases, drugs, mechanisms, or biomarkers are relevant for this entity based on current knowledge.\nIf you need information on functional translation initiation factors (e.g., EIF4E, EIF4B, EIF4A), please clarify, and structured details can be provided for the correct target[2][3].

Other names

EIF4B pseudogene 7

None, as no drugs target this pseudogene